A diagnostic chip automatically monitors sensor health every five minutes to improve sensor performance and reduce variability.
Our most accurate sensor to date.§
Expect up to seven days of sensor life and a shorter start-up time.
The Guardian™ Sensor (3) is approved by Health Canada to be worn on either the abdomen, buttocks or on the back of the arm.†
Integrated with our latest advancement in insulin pump therapy, the Guardian Sensor (3) enables different levels of automation that fit your lifestyle.
A web-based program that collects information directly from your Medtronic diabetes management system. It allows you to generate reports that can be used during your doctor’s visits and to monitor your own progress.
The intelligent diagnostics of the transmitter are continuously and proactively monitoring the health of the sensor. Guardian™ Sensor (3) can be worn for up to 7 days, however if your sensor is not performing well, you may receive a Change Sensor alert. Each monthly box of sensors includes 30 days of sensor wear to ensure you are only provided with safe, reliable and accurate sensor glucose values.
Guardian™ Sensor (3) can be worn on the abdomen or arm of those aged 14 years or older. When used with the MiniMed 670G, it can be worn on the abdomen or buttocks for ages 7 - 13. When used with the Guardian Connect CGM System, it can be worn on the abdomen or buttocks for ages 3 - 13..†
Guardian™ Sensor (3) is compatible with MiniMed™ 670G insulin pump and the standalone Guardian Connect CGM System.
Extra tape will be available soon on our eShop. Tegaderm and IV3000 are available substitutes and can be purchased on our eShop or through our customer service department.
If you are experiencing a problem with your Guardian™ Sensor (3), please contact the 24-hour helpline at 1-800-284-4416.
Guardian™ Sensor (3) is the newest sensor from Medtronic. It is the only sensor on the market that is licensed to power the MiniMed 670G self-adjusting insulin pump and the Guardian Connect standalone CGM System. It is more accurate1 and comfortable§ than previous sensors.
The Guardian Connect CGM System is intended for monitoring glucose levels in persons aged 3 years or older with diabetes mellitus. The MiniMed 670G system is intended for the management of Type 1 diabetes mellitus in persons age 7 and older requiring insulin.
In Canada, for persons 7-13 years of age, sensor placement and insertion has been studied in the belly (abdomen) and buttocks only and is not licensed for other sites.
For persons that are 14 years of age and older, sensor placement and insertion has been studied in the belly (abdomen) and back of upper arm only and is not licensed for other sites.
The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.
Data on file. 2019
MiniMed™ 670G System SSED. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=p160017. Accessed July 31, 2018. Arm insertion, 3-4 calibrations per day.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.